Literature DB >> 3592131

The Immunodeficiency Cancer Registry. A research resource.

A H Filipovich, K J Heinitz, L L Robison, G Frizzera.   

Abstract

The Immunodeficiency Cancer Registry (ICR) contains nearly 500 case records regarding patients with primary immunodeficiencies who have developed malignancies. There is a proportional excess of lymphomas (50.7%) among the ICR cases and more than one-half of these cases were diagnosed at less than 10 years of age. Information in the ICR database is accessible to investigators conducting research on the biology or epidemiology of cancers associated with immunodeficiency.

Entities:  

Mesh：

Year:  1987        PMID： 3592131     DOI： 10.1097/00043426-198722000-00017

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN： 0192-8562


  19 in total

1.  Increased frequency of hematopoietic malignancies in relatives of patients with lymphoid neoplasms: a French case-control study.

Authors:  Sara Villeneuve; Laurent Orsi; Alain Monnereau; Christian Berthou; Pierre Fenaux; Gerald Marit; Pierre Soubeyran; Françoise Huguet; Noël Milpied; Michel Leporrier; Denis Hemon; Xavier Troussard; Jacqueline Clavel
Journal:  Int J Cancer       Date:  2009-03-01       Impact factor: 7.396

2.  Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the Center for International Blood and Marrow Transplant Research.

Authors:  Naynesh R Kamani; Shimareet Kumar; Anna Hassebroek; Mary Eapen; Jennifer LeRademacher; James Casper; Morton Cowan; José Sánchez de Toledo; Alina Ferster; Paul Szabolcs; John R Wingard; Edwin Horwitz; Alexandra H Filipovich
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-20       Impact factor: 5.742

3.  Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Michaela R Richardson; Richard F Ambinder; Debra L Friedman; Sally L Glaser; Alain Monnereau; Logan G Spector; Julie A Ross; Seymour Grufferman
Journal:  Int J Cancer       Date:  2015-05-19       Impact factor: 7.396

4.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

5.  Juxtaposition of the T-cell receptor alpha-chain locus (14q11) and a region (14q32) of potential importance in leukemogenesis by a 14;14 translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia.

Authors:  M P Davey; V Bertness; K Nakahara; J P Johnson; O W McBride; T A Waldmann; I R Kirsch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 6.  Primary central nervous system lymphoma.

Authors:  W S Velasquez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.

Authors:  Amy M Linabery; Erik B Erhardt; Rachel K Fonstad; Richard F Ambinder; Greta R Bunin; Julie A Ross; Logan G Spector; Seymour Grufferman
Journal:  Int J Cancer       Date:  2014-03-18       Impact factor: 7.396

8.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  Children's Oncology Group's 2013 blueprint for research: non-Hodgkin lymphoma.

Authors:  Catherine M Bollard; Megan S Lim; Thomas G Gross
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

10.  Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.

Authors:  E F Kent; J Crawford; H J Cohen; R H Buckley
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.